In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Ischemic heart disease risk factors in patients with surgical menopause

Session Poster Session III - Friday 08:30 - 12:30

Speaker Natalia Lareva

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Topic : preventive cardiology
  • Sub-topic : Lipids
  • Session type : Poster Session

Authors : N Lareva (Chita,RU), A Govorin (Chita,RU)

Authors:
N Lareva1 , A Govorin1 , 1Chita State Medical Academy - Chita - Russian Federation ,

Citation:

Objective: To estimate the ischemic heart disease risk factors in women with surgical menopause.

Methods: 141 women with surgical menopause were included in the investigation. All of them underwent general clinical examination, body mass index (BMI) calculation, measurement of waist circumference, menopausal index evaluation, ambulatory blood pressure and electrocardiogram monitoring (Cardiotens-01, Meditech), determination of general cholesterol, lipid fractions and glucose tolerance. We also measured the level of non-etherized fatty acids and glycerol in blood serum and calculated its` proportion. Postmenopausal women were 45,3±2,8 years old; the duration of menopause was from 6 months to 7 years. The expression of menopausal syndrome was assessed according to the menopausal index dimension, which was 41,3±11,06 score. Control group consisted of 17 healthy women (mean age 37,2±4,2). Patients with coronary heart disease, essential hypertension, endocrine and grievous somatic diseases were excluded. Statistical method such as Mann-Whitney test was used

Results: Almost all postmenopausal women had 2 or more attributes of menopausal metabolic syndrome: obesity (BMI 32,6±1,4 kg\m2) with the prevalence of visceral adipose tissue (waist circumference = 80 cm) – 78%, hypercholesterolemia – 62%, hypertriglyceridemia – 75%, pathological glucose tolerance – 45%, arterial hypertension, stages 1-2 – 68%. Moreover, it was found, that the level of non-etherized fatty acids in patients with surgical menopause consisted 134% from the level of this index in healthy women (p<0,05); and the level of glycerol was decreased in 29% (p<0,05). The ratio of non-etherized fatty acids to glycerol permits to estimate the velocity of substrate utilization by peripheral tissues and myocardium as well. This index in postmenopausal women was  42% more than in control group (p<0,01). We can conclude that the level of non-etherized fatty acids increases not only owing to lipolytic  process activation, but results from the disturbances of this substrate utilization. The increase of non-etherized fatty acids level contributes to the development of insulin resistance, which is the key link of menopausal metabolic syndrome. Conclusions. Thus, postmenopausal women have expressive disorders in lipid and glucose metabolism, which cause rapid atherosclerosis development in these patients.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are